Digistain
Best Transformational Breast Cancer Biomarker Analytics Firm 2026 - UK
Digistain is a UK-based MedTech SME at the forefront of personalised medicine. Its novel AI-enabled spectroscopic platform delivers rapid, low-cost risk stratification to guide adjuvant chemotherapy decisions for breast cancer patients. By offering a faster and more affordable alternative to incumbent technologies, Digistain is helping to expand equitable access to precision cancer care worldwide.